Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL).
Fiche publication
Date publication
avril 2016
Journal
Annals of oncology : official journal of the European Society for Medical Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr CASASNOVAS Olivier
Tous les auteurs :
Cottereau AS, Becker S, Broussais F, Casasnovas O, Kanoun S, Roques M, Charrier N, Bertrand S, Delarue R, Bonnet C, Hustinx R, Gaulard P, de Leval L, Vera P, Itti E, Mounier N, Haioun C, Tilly H, Meignan M
Lien Pubmed
Résumé
Most peripheral T-cell lymphoma (PTCL) patients have a poor outcome and the identification of prognostic factors at diagnosis is needed.
Mots clés
Adult, Aged, Aged, 80 and over, Anthracyclines, administration & dosage, Disease-Free Survival, Female, Fluorodeoxyglucose F18, Humans, Lymphoma, T-Cell, Peripheral, diagnostic imaging, Male, Middle Aged, Positron Emission Tomography Computed Tomography, Prognosis, Tumor Burden
Référence
Ann. Oncol.. 2016 Apr;27(4):719-24